SERUM-LIPID AND APOLIPOPROTEIN LEVELS IN NONHYPERTENSIVE LEAN NIDDM PATIENTS

被引:1
|
作者
IKEDA, T
OCHI, H
OHTANI, I
FUJIYAMA, K
HOSHINO, T
TANAKA, Y
TAKEUCHI, T
MASHIBA, H
机构
[1] First Department of Internal Medicine, Tottori University School of Medicine, Nishi-machi, Yonago
关键词
APOLIPOPROTEIN; GLYCEMIC CONTROL; HYPERTENSION; NIDDM; PROTEINURIA; SERUM LIPIDS;
D O I
10.1111/j.1365-2796.1991.tb00420.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine the possible role of a glycaemic control in lipid metabolism in non-insulin-dependent diabetes mellitus (NIDDM) patients, serum lipid and apolipoprotein levels were measured in well-controlled and poorly controlled lean NIDDM without proteinuria and hypertension. A sample of 96 lean NIDDM patients (body mass index < 25 kg m-2 in men and < 27 kg m-2 in women) were divided into two groups: group I, where the HbA1c concentration had been < 6% for the previous 3 months, and group II, where the HbA1c concentration had been > 8% for the previous 3 months. Serum total cholesterol, triglyceride, and HDL-cholesterol levels showed no significant differences between groups I and II. Furthermore, serum levels of apolipoproteins AI, AII, B, CII, CIII, and E did not differ significantly between groups I and II. These results suggest that glycaemic control did not influence lipid metabolism in lean NIDDM patients.
引用
收藏
页码:131 / 134
页数:4
相关论文
共 50 条
  • [1] SERUM-LIPID AND APOLIPOPROTEIN LEVELS IN PATIENTS WITH PSORIASIS
    SEISHIMA, M
    SEISHIMA, M
    MORI, S
    NOMA, A
    BRITISH JOURNAL OF DERMATOLOGY, 1994, 130 (06) : 738 - 742
  • [2] SERUM-LIPID, APOLIPOPROTEIN AND LIPOPARTICLE LEVELS IN THE HUMAN FETUS
    LEGRAS, B
    DUROU, MR
    RUELLAND, A
    GALLOU, G
    JEZEQUEL, C
    CLOAREC, L
    PRENATAL DIAGNOSIS, 1995, 15 (03) : 225 - 228
  • [3] SERUM-LIPID AND APOLIPOPROTEIN LEVELS IN A TIBETAN POPULATION-SAMPLE
    KESTELOOT, H
    HUANG, DX
    ZOU, XD
    SONG, A
    COBBAERT, C
    ACTA CARDIOLOGICA, 1990, 45 (06) : 455 - 462
  • [4] SERUM-LIPID LEVELS OF PATIENTS WITH EPILEPSY
    FROSCHER, W
    MICHELSEN, A
    MAIER, V
    KELLER, F
    WOLFERSDORF, M
    EPILEPSIA, 1995, 36 : S229 - S229
  • [5] SERUM-LIPID AND APOLIPOPROTEIN LEVELS IN A NIGERIAN POPULATION-SAMPLE
    KESTELOOT, H
    OVIASU, VO
    OBASOHAN, AO
    OLOMU, A
    COBBAERT, C
    LISSENS, W
    ATHEROSCLEROSIS, 1989, 78 (01) : 33 - 38
  • [6] SERUM-LIPID AND APOLIPOPROTEIN-A AND APOLIPOPROTEIN-B LEVELS IN FAMILIAL HYPERCHOLESTEROLEMIA
    CRAIG, IH
    POULIS, P
    HILL, G
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1983, 13 (03): : 241 - 246
  • [7] RELATIONS BETWEEN NUTRIENT INTAKE AND SERUM-LIPID AND APOLIPOPROTEIN LEVELS
    GONZALEZREQUEJO, A
    SANCHEZBAYLE, M
    BAEZA, J
    ARNAIZ, P
    VILA, S
    ASENSIO, J
    RUIZJARABO, C
    JOURNAL OF PEDIATRICS, 1995, 127 (01): : 53 - 57
  • [8] EFFECTS OF PINACIDIL ON SERUM-LIPID, LIPOPROTEIN, AND APOLIPOPROTEIN LEVELS IN PATIENTS WITH MILD TO MODERATE HYPERTENSION
    SAKU, K
    YING, H
    ARAKAWA, K
    CLINICAL THERAPEUTICS, 1990, 12 (02) : 132 - 138
  • [9] EFFECTS OF AROTINOLOL ON SERUM-LIPID AND APOLIPOPROTEIN LEVELS IN PATIENTS WITH MILD ESSENTIAL-HYPERTENSION
    SASAKI, J
    HANDA, K
    ARAKAWA, K
    CLINICAL THERAPEUTICS, 1989, 11 (05) : 580 - 583
  • [10] EFFECT OF TRAPIDIL ON SERUM-LIPID AND APOLIPOPROTEIN LEVELS IN PATIENTS WITH ISCHEMIC-HEART-DISEASE
    KOTAKE, H
    SAWADA, Y
    HOSHIO, A
    SHIROTA, K
    NAWADA, T
    YOSHIDA, A
    HISATOME, I
    MIYAKODA, H
    MASHIBA, H
    GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1993, 24 (02): : 387 - 389